- Wednesday, July 15, 2020
13 July 2020
For immediate release
3Sixty Biopharmaceuticals Partners with Jubilant Generics to supply Remdesivir IV in Southern Africa
3Sixty Biopharmaceuticals (Pty) Ltd (3Sxity Biopharma), a division of 3Sixty Global Solutions Group (3SixtyGSG) has partnered with Jubilant Generics, a subsidiary of Jubilant life sciences Limited to supply Remdesivir for the treatment of COVID-19 infection in Southern Africa. On the 12th May 2020, Jubilant Life Sciences entered into Licensin...